Chris Dixon and Sarah Mervosh, The New York Times
Published: 30 Jan 2021 08:19 AM BdST
Updated: 30 Jan 2021 08:19 AM BdST A person gets a temperature check before entering a COVID-19 vaccine site in Greenville, SC, on Tuesday, Jan 26, 2021, where Prisma Health converted an empty retail space into a vaccine centre. The New York Times
South Carolina was already experiencing one of the worst coronavirus outbreaks in the nation when officials got word this week of an alarming development: A new, more concerning variant of the virus, originally identified in South Africa, had been detected in the state. );
}
Not long after, a second case was discovered with no known connection to the first, state officials announced Thursday.
Covid-19 Live Updates: Countries Around the World Tighten Borders to Evade Virus Variants nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
T cells target broad range of SARS-CoV-2 epitopes, study shows
6
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
A new study has suggested that T cells combat SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the virus’s Spike (S) protein. By attacking the coronavirus from many angles, the body can potentially recognise different SARS-CoV-2 variants. The study was led by scientists at La Jolla Institute for Immunology (LJI), US.
According to the scientists, the new research is the most detailed analysis so far of which proteins on SARS-CoV-2 stimulate the strongest responses from the immune system’s “helper” CD4+ T cells and “killer” CD8+ T cells.
Immune system’s T cells can mount attacks against many coronavirus targets even on new variants, LJI says
An electron micrograph shows SARS-CoV-2 particles isolated from a patient.
(National Institute of Allergy and Infectious Diseases)
By La Jolla Institute for Immunology
Jan. 27, 2021 4:11 PM PT
A new study led by scientists at the La Jolla Institute for Immunology suggests that T cells try to fight SARS-CoV-2, the coronavirus that causes COVID-19, by targeting a broad range of sites on the virus. By attacking the virus from many angles, the body has the tools to potentially recognize different SARS-CoV-2 variants.
The new research, published Jan. 27 in
Study provides a detailed look at vulnerable sites on SARS-CoV-2
A new study led by scientists at La Jolla Institute for Immunology (LJI) suggests that T cells try to fight SARS-CoV-2 by targeting a broad range of sites on the virus beyond the key sites on the virus s spike protein. By attacking the virus from many angles, the body has the tools to potentially recognize different SARS-CoV-2 variants.
The new research, published January 27, 2021 in
Cell Report Medicine, is the most detailed analysis so far of which proteins on SARS-CoV-2 stimulate the strongest responses from the immune system s helper CD4+ T cells and killer CD8+ T cells.